Article

Dr. Shields to receive national award

Jerry A. Shields, MD, director of the Wills Eye Ocular Oncology Service, has been named to receive the National Physician of the Year Award in Clinical Excellence.

 

Philadelphia-Jerry A. Shields, MD, director of the Wills Eye Ocular Oncology Service, has been named to receive the National Physician of the Year Award in Clinical Excellence. The Awards recognize and honor five exemplary physicians and are given to physicians who are nationally recognized leaders and contributors in their specialties.

 For 40 years, Dr. Shields has diagnosed and treated countless patients with ocular tumors and has led clinical research to improve methods for the diagnosis and treatment of eye cancers, including tumors of the eyelids, conjunctiva, intraocular structures, and orbit. He is also professor of ophthalmology at Thomas Jefferson University Hospital.

“Dr. Jerry Shields, along with Dr. Carol Shields, his partner both personally and professionally, are among the exemplary Wills models of the best minds and caring hearts in medicine today,” said Wills Eye Ophthalmologist-in-Chief Julia A. Haller, MD. “We are so lucky to have Jerry at Wills, where he trained and started his remarkable career path that ultimately changed the world of ocular oncology. The Shields' practice has built our exceptional training program in ocular oncology and set the paradigm for fighting eye cancer.”

Dr. Shields has served on the editorial boards for numerous ophthalmology journals and was selected as the first president of the International Society of Ocular Oncology, representing all ocular oncology specialists worldwide. He has authored or co-authored more than 1,200 articles in peer-reviewed scientific journals, written more than 500 textbook chapters, and has authored or co-authored 11 major textbooks related to ocular tumors.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.